Key Points - Rongbai Technology has signed a cooperation agreement with CATL, becoming its primary supplier of sodium battery cathode materials, with a commitment to supply at least 60% of CATL's total procurement volume if certain conditions are met [4] - Maihe Co.'s chairman and actual controller has been placed under investigation, with the general manager taking over the chairman's responsibilities [5] - Fudan Microelectronics will see Guosheng Investment become its largest shareholder after acquiring 12.99% of its shares [6][7] - Guolian Minsheng has received approval for stock option market-making business from the China Securities Regulatory Commission [8] - Luoping Zinc & Electric's subsidiary has received approval to resume production at its lead-zinc mine [9] - Heshun Petroleum's actual controller plans to transfer 6% of the company's shares through an agreement, with no change in control expected [10] - Furi Co. has stated that it currently has no plans for capacity expansion despite stock price fluctuations [11] - Joyoung Co. clarified that it operates in the small home appliance sector and does not engage in food and beverage production [12] - Huaxia Happiness reported abnormal stock trading but confirmed no undisclosed major events aside from a pre-restructuring notice [13] - Zhongsheng Pharmaceutical is advancing several clinical trials, but the outcomes remain uncertain [14] - Pingtan Development noted that its stock price has risen sharply without significant changes in fundamentals, indicating potential market overreaction [15] Shareholding Changes - Chahua Co.'s major shareholder plans to reduce its stake by up to 3% [16] - Qianli Technology's shareholder intends to reduce its stake by up to 2% [17] - Gaoling Information's shareholders plan to collectively reduce their stake by up to 1.5% [18] - Guochuang High-tech's major shareholder plans to reduce its stake by up to 1% [19] - China Aluminum's director plans to reduce a very small percentage of shares [20] - Shikong Technology plans to reduce up to 0.29% of its repurchased shares [21] - Xinong Co.'s director plans to reduce up to 0.1925% of shares [22] - Yifeng Pharmacy's vice presidents plan to reduce a total of 213,900 shares [23] Major Contracts - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 168.12 million yuan [24]

Core Points - Fudan Microelectronics announced that Shanghai Guosheng Group intends to acquire 12.99% of its shares from Fudan Microelectronics' subsidiary, becoming the largest shareholder [1][2] - The share transfer price is set at 48.2 yuan per share, totaling 5.144 billion yuan [2] - The company will remain without a controlling shareholder or actual controller after the transfer [2] Company Overview - Fudan Microelectronics, established in 1998, specializes in the design, development, and production of integrated circuits and related solutions [6] - The company is known for its products including security and identification chips, non-volatile memory, smart meter chips, and FPGA [6] - Fudan Microelectronics was the first listed joint-stock integrated circuit design enterprise in China [6] Strategic Implications - The share transfer is part of a broader trend of reform in state-owned asset management and aims to enhance collaboration between university technology assets and local state-owned platforms [6][4] - Fudan University will continue to support the company's development and maintain strategic cooperation with Fudan Microelectronics [6] - The collaboration aims to integrate basic research, technology development, and industrial transfer, fostering a synergistic development model [6] Investor Background - Shanghai Guosheng Group, the controlling entity of Guosheng Investment, has significant investments in the integrated circuit sector and financial services [7] - The group has previously invested in various technology companies, indicating a strong commitment to the semiconductor industry [7]

（文章来源：证券日报） 证券日报网讯 11月16日晚间，复旦微电发布公告称，复芯凡高和国盛投资近日签署了《上海复芯凡高 集成电路技术有限公司与上海国盛集团投资有限公司关于上海复旦微电子集团股份有限公司之股份转让 框架协议》。国盛投资拟以协议转让方式受让复芯凡高持有的复旦微电106，730，000股A股股份，占 复旦微电股份总数的12.99%。本次转让完成后，国盛投资将成为上市公司第一大股东。上市公司仍然 为无控股股东、无实际控制人状态，不会对上市公司的经营管理构成重大影响，不涉及要约收购。 ...

上海复旦(01385)发布公告，上海复芯凡高集成电路技术有限公司(以下简称"复芯凡高")和上海国盛集团 投资有限公司(以下简称"国盛投资")近日签署了《上海复芯凡高集成电路技术有限公司与上海国盛集团 投资有限公司关于上海复旦微电子集团股份有限公司之股份转让框架协议》(以下简称"《股份转让框架 协议》")。国盛投资拟以协议转让方式受让复芯凡高持有的上海复旦微电子集团股份有限公司(以下简 称"复旦微电""上市公司"或"标的公司")1.067亿股A股股份，占复旦微电股份总数的12.99%(以下简称"标 的股份")。本次转让完成后，国盛投资将成为上市公司第一大股东。上市公司仍然为无控股股东、无实 际控制人状态，不会对上市公司的经营管理构成重大影响，不涉及要约收购。 ...

智通财经APP讯，上海复旦(01385)发布公告，上海复芯凡高集成电路技术有限公司(以下简称"复芯凡 高")和上海国盛集团投资有限公司(以下简称"国盛投资")近日签署了《上海复芯凡高集成电路技术有限 公司与上海国盛集团投资有限公司关于上海复旦微电子集团股份有限公司之股份转让框架协议》(以下 简称"《股份转让框架协议》")。国盛投资拟以协议转让方式受让复芯凡高持有的上海复旦微电子集团 股份有限公司(以下简称"复旦微电""上市公司"或"标的公司")1.067亿股 A 股股份，占复旦微电股份总数 的 12.99%(以下简称"标的股份")。本次转让完成后，国盛投资将成为上市公司第一大股东。上市公司仍 然为无控股股东、无实际控制人状态，不会对上市公司的经营管理构成重大影响，不涉及要约收购。 ...

(股 份 編 號: 1385) 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因公告全部或任何部份內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 上海復旦微電子集團股份有限公司 Shanghai Fudan Microelectronics Group Company Limited* (在 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ) 海外監管公告 本公告乃上海復旦微電子集團股份有限公司（「本公司」）根據香港聯合交易所有限公司 證券上市規則第 13.10B 條的規定刊發。 茲載列本公司於上海證券交易所網站刊發的《詳式權益變動報告書》，僅供參閱。 承董事會命 上 海 復 旦 微 電 子 集 團 股 份 有 限 公 司 董事長 張衛先生 中國，上海，2025 年 11 月 10 日 於本公告日期，本公司之執行董事為張衛先生及沈磊先生； 非執行董事為閆娜女士、 莊啟飛先生、張睿女士及宋加勒先生；獨立非執行董事為石艶玲女士、王美娟女士及胡 雪先生。 *僅供識別 上海复旦微电子集团股份有限公司 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因公告全部或任何部份內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 上海復旦微電子集團股份有限公司 Shanghai Fudan Microelectronics Group Company Limited* (在 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ) (股 份 編 號: 1385) 海外監管公告 本公告乃上海復旦微電子集團股份有限公司（「本公司」）根據香港聯合交易所有限公司 證券上市規則第 13.10B 條的規定刊發。 茲載列本公司於上海證券交易所網站刊發的《簡式權益變動報告書》，僅供參閱。 承董事會命 上 海 復 旦 微 電 子 集 團 股 份 有 限 公 司 董事長 張衛先生 中國，上海，2025 年 11 月 16 日 於本公告日期，本公司之執行董事為張衛先生及沈磊先生； 非執行董事為閆娜女士、 莊啟飛先生、張睿女士及宋加勒先生；獨立非執行董事為石艶玲女士、王美娟女士及胡 雪先生。 *僅供識別 上海复旦微电子集团股份有限公司 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 上海復旦微電子集團股份有限公司 Shanghai Fudan Microelectronics Group Company Limited* (在 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ) (股 份 編 號 : 1385) 内幕消息 關於公司持股5%以上股東簽署股份轉讓框架協議 暨第一大股東擬發生變更 本公告乃上海復旦微電子集團股份有限公司董事會（「董事會」）根據香港聯合交易所有 限公司主板證券上市規則（「上市規則」）第 13.09 條及香港法例第 571 章證券及期貨條 例第 XIVA 部項下內幕消息條文（定義見上市規則）而作出。 上海復芯凡高集成電路技術有限公司（以下簡稱"復芯凡高"）和上海國盛集團投資有 限公司（以下簡稱"國盛投資"）近日簽署了《上海復芯凡高集成電路技術有限公司與 上海國盛集團投資有限公司關於上海復旦微電子集團股份有限公司之股份轉讓框架協 議》（以下 ...

Group 1 - Rongbai Technology signed a cooperation agreement with CATL, making Rongbai the primary supplier of sodium battery cathode powder, with a commitment to purchase at least 60% of its total procurement volume annually, potentially reaching 500,000 tons [3] - Meihe Co.'s controlling shareholder and chairman Wang Jinping is under investigation and has been placed under detention, with the general manager Zhang Kaixu taking over the chairman's responsibilities [4] - Fudan Microelectronics announced that Guosheng Investment plans to acquire 12.99% of its shares from Fuxin Fangao, making Guosheng the largest shareholder post-transfer [5] Group 2 - Guolian Minsheng received approval for stock option market-making business from the China Securities Regulatory Commission [6] - Luoping Zinc Electric's subsidiary has received approval to resume production at the Jinpo lead-zinc mine, having met safety and operational requirements [7] - Heshun Petroleum's actual controller and associates plan to transfer 6% of the company's shares through an agreement, maintaining control post-transfer [8] Group 3 - Furi Co. stated that there are currently no expansion plans for its new energy sector, amid stock price volatility and potential irrational speculation [9] - Joyoung Co. clarified that it operates in the small home appliance sector and does not engage in food and beverage production, despite recent market speculation [10][11] - Huaxia Happiness reported abnormal stock trading but confirmed no undisclosed significant matters aside from its pre-restructuring announcement [12] Group 4 - Zhongsheng Pharmaceutical is advancing several clinical trials for its innovative drugs, but the outcomes remain uncertain, including the approval and market competition for its products [13] - Pingtan Development noted that its stock price has risen sharply without significant changes in fundamentals, indicating potential market overreaction [14] Group 5 - Chahua Co. announced that its major shareholder plans to reduce its stake by up to 3% within three months [16] - Qianli Technology's major shareholder intends to reduce its stake by up to 2% through a targeted sale [17] - Gaoling Information's shareholders plan to collectively reduce their holdings by up to 1.5% due to funding needs [18] Group 6 - Guochuang High-tech's major shareholder plans to reduce its stake by up to 1% within three months [19][20] - China Aluminum's director plans to sell a minimal stake of 0.00034% due to personal funding needs [21] - Shikong Technology plans to reduce its repurchased shares by up to 0.29% [22] Group 7 - Xinong Co.'s director plans to reduce his stake by up to 0.1925% due to personal funding needs [23] - Yifeng Pharmacy's vice presidents plan to collectively reduce their holdings by up to 213,900 shares due to personal funding needs [24] Group 8 - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid, with an estimated total bid amount of approximately 168.12 million yuan [26]

复旦微电(688385)11月16日晚公告，上海复芯凡高集成电路技术有限公司（简称"复芯凡高"）和上海国 盛集团投资有限公司（简称"国盛投资"）近日签署了《股份转让框架协议》。国盛投资拟受让复芯凡高 持有的上市公司1.07亿股A股股份，占复旦微电股份总数的12.99%。本次转让完成后，国盛投资将成为 上市公司第一大股东。上市公司仍无控股股东及无实际控制人，不会对上市公司的经营管理构成重大影 响，不涉及要约收购。 本次转让前，复芯凡高持有复旦微电12.99%股份，国盛投资未持有复旦微电股份。本次转让完成后， 复芯凡高不再持有复旦微电股份，国盛投资将持有复旦微电12.99%股份。 国盛投资本次受让上市公司12.99%的股权，系根据自身战略发展的需要进行的，暂无在未来12个月内 继续增持或处置上市公司股份的计划。 值得注意的是，根据双方签署的协议，本次股份转让完成后，复芯凡高及其实际控制人复旦大学将继续 支持和保持复旦微电与复旦大学之间的战略合作关系与产学研协同合作，支持复旦微电与复旦大学继续 深化合作机制，共同建设创新中心相关实体科研平台。 复芯凡高经营范围包括微电子、通讯、自动化仪表、计算机、生物、医学电子专业 ...